OnKure Therapeutics Statistics
 Total Valuation
 OKUR has a market cap or net worth of $45.46 million. The enterprise value is -$37.23 million.
 Important Dates
 The next estimated earnings date is Wednesday, November 12, 2025, after market close.
 | Earnings Date | Nov 12, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 OKUR has 13.53 million shares outstanding. The number of shares has decreased by -25.13% in one year.
 | Current Share Class | 12.84M | 
| Shares Outstanding | 13.53M | 
| Shares Change (YoY) | -25.13% | 
| Shares Change (QoQ) | +0.63% | 
| Owned by Insiders (%) | 17.25% | 
| Owned by Institutions (%) | 52.07% | 
| Float | 5.80M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| Forward PS | n/a | 
| PB Ratio | 0.58 | 
| P/TBV Ratio | 0.58 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
 The company has a current ratio of 11.13, with a Debt / Equity ratio of 0.01.
 | Current Ratio | 11.13 | 
| Quick Ratio | 10.97 | 
| Debt / Equity | 0.01 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -518.93 | 
Financial Efficiency
 Return on equity (ROE) is -142.90% and return on invested capital (ROIC) is -86.33%.
 | Return on Equity (ROE) | -142.90% | 
| Return on Assets (ROA) | -70.95% | 
| Return on Invested Capital (ROIC) | -86.33% | 
| Return on Capital Employed (ROCE) | -80.68% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -$1.31M | 
| Employee Count | 46 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
  | Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -80.79% in the last 52 weeks.
 | Beta (5Y) | n/a | 
| 52-Week Price Change | -80.79% | 
| 50-Day Moving Average | 2.81 | 
| 200-Day Moving Average | 3.29 | 
| Relative Strength Index (RSI) | 61.20 | 
| Average Volume (20 Days) | 154,177 | 
Short Selling Information
 The latest short interest is 65,129, so 0.48% of the outstanding shares have been sold short.
 | Short Interest | 65,129 | 
| Short Previous Month | 174,585 | 
| Short % of Shares Out | 0.48% | 
| Short % of Float | 1.12% | 
| Short Ratio (days to cover) | 0.74 | 
Income Statement
  | Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -63.31M | 
| Pretax Income | -60.31M | 
| Net Income | -60.31M | 
| EBITDA | -62.84M | 
| EBIT | -63.31M | 
| Earnings Per Share (EPS) | -$6.02 | 
 Full Income StatementBalance Sheet
 The company has $83.37 million in cash and $823,000 in debt, giving a net cash position of $82.55 million or $6.10 per share.
 | Cash & Cash Equivalents | 83.37M | 
| Total Debt | 823,000 | 
| Net Cash | 82.55M | 
| Net Cash Per Share | $6.10 | 
| Equity (Book Value) | 78.17M | 
| Book Value Per Share | 5.78 | 
| Working Capital | 76.96M | 
 Full Balance SheetCash Flow
 In the last 12 months, operating cash flow was -$61.29 million and capital expenditures -$64,000, giving a free cash flow of -$61.36 million.
 | Operating Cash Flow | -61.29M | 
| Capital Expenditures | -64,000 | 
| Free Cash Flow | -61.36M | 
| FCF Per Share | -$4.53 | 
 Full Cash Flow StatementMargins
  | Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
 OKUR does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | 25.13% | 
| Shareholder Yield | 25.13% | 
| Earnings Yield | -133.07% | 
| FCF Yield | -135.37% | 
 Analyst Forecast
 The average price target for OKUR is $32.25, which is 859.82% higher than the current price. The consensus rating is "Strong Buy".
 | Price Target | $32.25 | 
| Price Target Difference | 859.82% | 
| Analyst Consensus | Strong Buy | 
| Analyst Count | 4 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
  | Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |